SQUASSINA, ALESSIO
 Distribuzione geografica
Continente #
EU - Europa 225.154
NA - Nord America 13.506
AS - Asia 6.413
SA - Sud America 1.289
Continente sconosciuto - Info sul continente non disponibili 807
AF - Africa 211
OC - Oceania 29
Totale 247.409
Nazione #
IT - Italia 221.868
US - Stati Uniti d'America 13.157
SG - Singapore 2.407
CN - Cina 1.975
BR - Brasile 978
VN - Vietnam 699
SE - Svezia 681
UA - Ucraina 520
DE - Germania 448
GB - Regno Unito 408
FI - Finlandia 353
HK - Hong Kong 288
FR - Francia 286
CA - Canada 203
BD - Bangladesh 194
IN - India 175
NL - Olanda 146
AR - Argentina 117
KR - Corea 113
MX - Messico 79
IQ - Iraq 68
JP - Giappone 68
TR - Turchia 66
AT - Austria 57
ES - Italia 56
ZA - Sudafrica 56
MA - Marocco 52
RU - Federazione Russa 52
PL - Polonia 51
EC - Ecuador 48
ID - Indonesia 40
BE - Belgio 38
CO - Colombia 37
SA - Arabia Saudita 33
VE - Venezuela 33
IE - Irlanda 31
PK - Pakistan 31
UZ - Uzbekistan 30
AU - Australia 28
PH - Filippine 26
CL - Cile 24
MY - Malesia 22
NO - Norvegia 21
CZ - Repubblica Ceca 20
IR - Iran 18
JO - Giordania 18
EG - Egitto 17
LT - Lituania 17
PY - Paraguay 17
AE - Emirati Arabi Uniti 16
JM - Giamaica 16
AZ - Azerbaigian 13
DK - Danimarca 13
IL - Israele 13
TN - Tunisia 13
CH - Svizzera 12
DZ - Algeria 12
KE - Kenya 12
KZ - Kazakistan 12
PE - Perù 12
PT - Portogallo 12
BO - Bolivia 10
GR - Grecia 10
NP - Nepal 10
PS - Palestinian Territory 10
UY - Uruguay 10
ET - Etiopia 8
QA - Qatar 8
CI - Costa d'Avorio 7
KG - Kirghizistan 7
LB - Libano 7
NI - Nicaragua 7
RS - Serbia 7
SN - Senegal 7
TH - Thailandia 7
DO - Repubblica Dominicana 6
GT - Guatemala 6
HR - Croazia 6
MD - Moldavia 6
NG - Nigeria 6
OM - Oman 6
RO - Romania 6
BB - Barbados 5
CR - Costa Rica 5
GE - Georgia 5
AM - Armenia 4
BG - Bulgaria 4
BY - Bielorussia 4
PA - Panama 4
PR - Porto Rico 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AL - Albania 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
HN - Honduras 3
IS - Islanda 3
KW - Kuwait 3
LV - Lettonia 3
Totale 246.550
Città #
Cagliari 215.375
Uta 5.408
Ashburn 1.266
Singapore 1.232
Fairfield 1.063
Dallas 927
San Jose 923
Woodbridge 765
Chandler 647
Houston 541
Boardman 488
Seattle 427
Wilmington 388
Beijing 387
Nyköping 348
Ann Arbor 341
Cambridge 338
Council Bluffs 332
New York 326
Los Angeles 292
Hong Kong 252
Jacksonville 247
Ho Chi Minh City 219
Helsinki 213
The Dalles 212
Santa Clara 211
Dearborn 175
Hefei 165
Shanghai 161
Lauterbourg 159
Hanoi 137
Boston 135
Rome 117
Nanjing 100
Seoul 99
Buffalo 96
São Paulo 92
Dong Ket 89
Columbus 78
Chicago 72
Frankfurt am Main 72
Orem 70
Milan 67
San Diego 62
Atlanta 61
Munich 61
Tokyo 59
Cardiff 58
Montreal 55
Nieuwegein 54
London 52
Redondo Beach 50
Redwood City 49
Norwalk 47
Nuremberg 47
Guangzhou 46
Toronto 46
Brooklyn 43
Johannesburg 43
Chennai 42
Lappeenranta 40
Warsaw 40
Phoenix 39
Brussels 36
Amsterdam 35
Denver 35
Rio de Janeiro 35
Shenyang 35
Tianjin 35
Casablanca 33
Hebei 33
Poplar 33
Da Nang 32
Nanchang 32
Stockholm 32
Changsha 31
San Francisco 31
Jiaxing 30
Mexico City 29
Haiphong 27
Naples 27
Vienna 26
Tashkent 24
Turku 24
Dublin 23
Verona 23
Hangzhou 22
Zhengzhou 22
Baghdad 21
Mountain View 21
Pune 20
Manchester 19
Oslo 19
Washington 19
Guayaquil 18
Orange 18
Sassari 18
Shenzhen 18
Berlin 17
Brasília 17
Totale 237.016
Nome #
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients 4.381
Count of “dark telomere” on the track of a biomarker for lithium treatment in bipolar disorder 4.268
Major depression subtypes are differentially associated with migraine subtype, prevalence and severity 3.633
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder 3.581
Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study 3.518
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.516
Challenges and Future Prospects of Precision Medicine in Psychiatry 3.430
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.156
Analysis of the influence of microRNAs in lithium response in bipolar disorder 3.070
Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients 3.056
Preliminary transcriptome analysis in lymphoblasts from cluster headache and bipolar disorder patients implicates dysregulation of circadian and serotonergic genes 3.055
Exploring the role of gut microbiota in major depressive disorder and in treatment resistance to antidepressants 3.022
Convergent analysis of genome-wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder 3.015
Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study 2.933
Association of polygenic score for major depression with response to lithium in patients with bipolar disorder 2.928
Exposure and duration of lithium treatment affect leukocyte telomere length in bipolar disorder patients 2.903
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.897
Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study 2.888
HDAC3 role in medication consumption in medication overuse headache patients: a pilot study 2.827
Involvement of core clock genes in lithium response 2.821
Differential effect of lithium on spermidine/spermine N1-acetiltransferase expression in suicidal behaviour 2.747
Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder. A genome-wide association study 2.719
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease 2.682
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.681
Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients 2.681
Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder 2.681
Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics 2.673
Increasing engagement in pharmacology and pharmacogenetics education using games and online resources: the PharmacoloGenius mobile app 2.657
null 2.498
Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder 2.469
Novel integrative genomic tool for interrogating lithium response in bipolar disorder 2.413
Pharmacogenomics of bipolar disorder 2.413
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample 2.384
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.363
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 2.308
Lithium pharmacogenetics: Where do we stand? 2.292
Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres? 2.233
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder 2.195
Cellular models to study bipolar disorder: a systematic review 2.184
Age at onset in bipolar disorder: investigation of the role of TaqIA polymorphism of DRD2 gene in a Sardinian sample 2.152
Lithium-induced differential expression of SAT1 in suicide completers and controls is not correlated with polymorphisms in the promoter region of the gene 2.108
557. Pharmacogenetic Association of Lithium Treatment Response with Bcl2 Polymorphism in Bipolar Disorder 2.090
Characterisation of age and polarity at onset in bipolar disorder 2.032
An examination of the quality and performance of the Alda scale for classifying lithium response phenotypes 2.009
Assessment of response to lithium maintenance treatment in bipolar disorder: A Consortium on Lithium Genetics (ConLiGen) report 1.986
null 1.980
Variant GADL1 and response to lithium in bipolar I disorder 1.979
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings 1.943
Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals 1.892
Lithium pharmacogenetics 1.863
A genetic risk score is differentially associated with migraine with and without aura 1.854
Positive Association Between REV-ERB Alpha Gene and Bipolar Disorder in a Sardinian Population 1.849
null 1.842
Candidate Genes in Bipolar 1 Sradinian Patients : A case control Study 1.825
The international consortium on lithium genetics (ConLiGen): An initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment 1.796
Doctors and researchers: integrating data for bipolar disorder studies 1.769
Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI 1.734
Zinc finger proteins in psychiatric disorders and response to psychotropic medications 1.677
A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics 1.674
Golden Helix Pharmacogenomics Days: educational activities on pharmacogenomics and personalized medicine. 1.669
Leukocyte telomere length is reduced in patients with major depressive disorder 1.668
Prediction of lithium response using genomic data 1.658
Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review 1.643
Treatment-Resistant Schizophrenia: Insights From Genetic Studies and Machine Learning Approaches 1.611
Insulin-like growth factor 1 differentially affects lithium sensitivity of lymphoblastoid cell lines from lithium responder and non-responder bipolar disorder patients 1.605
null 1.525
We are not alone in our body: insights into the involvement of microbiota in the etiopathogenesis and pharmacology of mental illness 1.523
Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment 1.507
null 1.449
null 1.424
null 1.414
A case-control association study of the PDLIM5 gene and bipolar disorder in a Sardinian sample 1.390
RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining 1.330
Telomere length in bipolar disorder and lithium response 1.311
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 1.279
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia 1.275
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.269
RNA sequencing of bipolar disorder lymphoblastoid cell lines implicates the neurotrophic factor HRP-3 in lithium clinical efficacy 1.260
Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patiens 1.255
Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions 1.235
Genetic, demographic and archival study on a Sardinian village (Escalaplano) Italy 1.231
Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study 1.208
Haplotype association study between DRD1 gene and parasuicide in bipolar disorder: Analysis of two samples from Canada and Sardinia 1.198
The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine 1.193
Assessment of the pharmacogenomics educational environment in southeast europe 1.188
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 1.173
null 1.161
null 1.156
null 1.146
Investigation of the genetic interaction between BDNF and DRD3 genes in suicidical behaviour in psychiatric disorders 1.122
Alzheimer’s disease: case-control study of polymorphisms in ACHE, CHAT and BCHE genes in a Sardininan sample 1.121
Candidate Genes in Bipolar 1 Sardinian Patients : A case control Study 1.063
The diacylglycerol kinase eta gene and bipolar disorder: a replication study in a Sardinian sample 1.056
HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders 1.024
Genetically elevated high-density lipoprotein cholesterol through cholesteryl ester transfer protein does not associate with risk of Alzheimer's disease 1.023
An introduction to pharmacogenomics and personalized medicine 1.020
Association study in a Sardinian sample between Bipolar Disorder and the nuclear receptor REV-ERBalpha gene, a critical component of the circadian clock system 1.016
A genome-wide association study of antidepressant-induced mania 993
2016 Golden Helix Summer School - Cancer Genomics and Individualized Therapy. 22-26 September 2016, Syros Island, Greece: Abstracts 981
Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy 974
Totale 202.572
Categoria #
all - tutte 322.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 322.121


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202212.389 0 965 810 1.128 1.149 840 868 680 1.363 1.464 1.732 1.390
2022/202320.269 1.298 2.583 2.690 1.780 1.547 2.277 977 1.292 1.482 1.494 1.874 975
2023/202420.567 915 746 795 1.387 1.949 3.193 3.207 1.447 981 1.349 2.332 2.266
2024/202553.948 16.213 17.375 4.848 4.853 2.500 2.695 3.298 211 496 443 395 621
2025/202615.411 1.126 722 1.825 1.636 1.249 1.195 2.273 1.323 957 1.766 890 449
2026/20271.014 396 618 0 0 0 0 0 0 0 0 0 0
Totale 247.409